Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
0(0%)
Results Posted
15%(2 trials)

Phase Distribution

Ph phase_2
1
8%
Ph phase_1
12
92%

Phase Distribution

12

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
12(92.3%)
Phase 2Efficacy & side effects
1(7.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

13 of 13 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(13)

Detailed Status

Completed13

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 112 (92.3%)
Phase 21 (7.7%)

Trials by Status

completed13100%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT03766581Phase 2

A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

Completed
NCT03196206Phase 1

Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment

Completed
NCT03698513Phase 1

A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

Completed
NCT03000673Phase 1

A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis

Completed
NCT03939702Phase 1

Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants

Completed
NCT02982707Phase 1

Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy Participants

Completed
NCT03224260Phase 1

To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants

Completed
NCT03362437Phase 1

Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants

Completed
NCT03341390Phase 1

An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants

Completed
NCT02608970Phase 1

Safety and Tolerability Study of BMS-986177 in Healthy Subjects

Completed
NCT02902679Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment

Completed
NCT02959060Phase 1

A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects

Completed
NCT02807909Phase 1

A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13